Tonix Pharmaceuticals Holding (TNXP) Inventory (2023 - 2026)

Tonix Pharmaceuticals Holding has reported Inventory for 4 years, with the latest figure at $4.7 million in Q2 2026.

• On a quarterly basis, Inventory fell 21.85% year-over-year to $4.7 million in Q2 2026; TTM through Jun 2026 was $4.7 million, a 21.85% decrease from a year earlier, with the FY2025 full-year figure at $6.0 million, down 28.48% from the prior year.
• Inventory was $4.7 million for Q2 2026 at Tonix Pharmaceuticals Holding, up from $3.6 million in the prior quarter.
• The five-year high for Inventory was $13.7 million in Q2 2023, with the low at $3.6 million in Q1 2026.
• Average Inventory over 4 years is $8.7 million, with a median of $8.1 million recorded in 2025.
• The largest YoY upside for Inventory was 21.85% in 2026 against a maximum downside of 55.2% in 2026.
• Over 4 years, Inventory stood at $13.6 million in 2023, then plunged by 38.35% to $8.4 million in 2024, then retreated by 28.48% to $6.0 million in 2025, then retreated by 22.2% to $4.7 million in 2026.
• The last three Inventory figures came in at $4.7 million (Q2 2026), $3.6 million (Q1 2026), and $6.0 million (Q4 2025), per Business Quant data.